BiomX Files Proxy Statement Amendment

Ticker: PHGE · Form: DEFA14A · Filed: Apr 17, 2025 · CIK: 1739174

Biomx Inc. DEFA14A Filing Summary
FieldDetail
CompanyBiomx Inc. (PHGE)
Form TypeDEFA14A
Filed DateApr 17, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, corporate-governance, amendment

TL;DR

BiomX filed proxy docs, nothing major revealed yet.

AI Summary

BiomX Inc. filed an amendment (Amendment No. 2) to its Definitive Proxy Statement (DEFA14A) on April 17, 2025. This filing concerns materials related to a shareholder meeting, but does not detail specific proposals or financial figures within the provided text. The company, formerly known as Chardan Healthcare Acquisition Corp. until April 30, 2018, is based in Ness Ziona, Israel.

Why It Matters

This filing indicates ongoing corporate governance activities and potential shareholder actions for BiomX Inc., which could impact its strategic direction and stock performance.

Risk Assessment

Risk Level: low — The filing is a procedural amendment to a proxy statement and does not contain new material financial information or significant corporate events.

Key Players & Entities

  • BiomX Inc. (company) — Registrant
  • Chardan Healthcare Acquisition Corp. (company) — Former company name
  • 20250417 (date) — Filing date
  • 20180430 (date) — Date of former company name change

FAQ

What is the purpose of this DEFA14A filing?

This filing is an amendment (Amendment No. 2) to a Definitive Proxy Statement (DEFA14A) for BiomX Inc., indicating it contains additional materials related to a shareholder meeting.

When was this amendment filed with the SEC?

This amendment was filed on April 17, 2025.

What was BiomX Inc. formerly known as?

BiomX Inc. was formerly known as Chardan Healthcare Acquisition Corp. until April 30, 2018.

Where is BiomX Inc. located?

BiomX Inc. is located at 22 Einstein St., 4th Floor, Ness Ziona, Israel.

Does this filing contain preliminary or definitive proxy materials?

The filing is marked as 'Definitive Additional Materials' and is an amendment to a Definitive Proxy Statement.

Filing Details

This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 17, 2025 regarding BiomX Inc. (PHGE).

View full filing on EDGAR

View Full Filing

View this DEFA14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.